Juris v. Inamed Corp., No. 10-12665 (11th Cir. 2012)Annotate this Case
This case arose from a 1999 class action suit against the maker of silicone breast implants. The U.S. District Court for the Northern District of Alabama approved a mandatory, limited fund class settlement which resolved tens of thousands of claims arising from injuries allegedly caused by defective implants manufactured by Inamed Corporation. In 2006, Zuzanna Juris filed an individual suit in California state court naming Inamed and its successor Allergan, alleging injuries caused by her Inamed implants. Defendants contended that Juris' lawsuit was barred by the 1999 class settlement. Juris countered that she could avoid the settlement's res judicata effect on due process grounds. The district court held that the class settlement precluded Juris from prosecuting the California case. Juris appealed, arguing, inter alia, that the method the Alabama court approved for distributing class notice was constitutionally deficient because she did not receive actual, individual notice. Upon review, the Eleventh Circuit concluded that Juris' assertion that she should have received actual, individual notice rested on a "faulty premise." Even assuming a heightened notice standard applied in this case, the Court concluded that Juris was unable to demonstrate that the notice in the class proceeding was constitutionally deficient. Finding no other error in the district court's holding that the class settlement precluded Juris' California case, the Eleventh Circuit affirmed that court's judgment.